Trademark owner · USPTO register · rebuilt nightly

Novartis AG

964 live US trademarks, filing since 1942. The 2nd largest trademark holder in Class 5 (pharmaceuticals). 38 new applications filed this year.

On the register as Novartis AG · NOVARTIS CORPORATION

Live marks
964
registered + pending
Registered
854
on the Principal Register
Pending
110
7 open to opposition
Filed in 2026
38
1 intent to use
Classes used
19
of 45 Nice classes
First filing
1942
84 years on the register
At a glanceplain-language reads of the register
Mostly pharmaceuticals: 800 of 964 live marks are in Class 5. Medical & beauty services (Class 44) is next with 100.
New products ahead: 1 of the 38 filings this year are intent-to-use applications, meaning the goods are not yet on sale.
7 marks are open to opposition now; the windows close between Nov 5 and Nov 19.
8 registrations have a maintenance filing due in the next 12 months, 8 already in the grace period.
Filing activityapplications per year, by filing date
0 175 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 38 so far

Marks held on the register, by filing date. 2026 is year to date.

Portfolio by classlive marks · rank among filers in that class

A multi-class mark counts once per class. Rank shown where the owner is in the class's top 50. Overall: #19 of all US filers.

Latest activity

What Novartis AG filed most recently.

MarkClassFiledBasisStatusSerial
VOKENTRU 5 Sep 10, 2026 — pending 50100830
XUNOVLIZ 5 Aug 14, 2026 — published · closes Nov 5 50051551
SYLPAXXO 5 Aug 14, 2026 — published · closes Nov 5 50051570
VURLIPAV 5 Aug 14, 2026 — published · closes Nov 5 50051580
HOVINBA 5 Jul 29, 2026 in use pending 79459354
JINIJY 5 Jul 27, 2026 in use pending 79459144
VILUMIQA 5 Jul 27, 2026 in use pending 79459145
JUSGARA 5 Jul 27, 2026 in use pending 79459146
WATTIGEO 5 Jul 27, 2026 in use pending 79459196
UNIQDOMI 5 Jul 27, 2026 in use pending 79459197
Open to opposition now30-day windows from publication
DEZELBY · Cl. 5 · published Oct 6
closes Nov 5
REZMUNIS · Cl. 5 · published Oct 6
closes Nov 5
XUNOVLIZ · Cl. 5 · published Oct 6
closes Nov 5
SYLPAXXO · Cl. 5 · published Oct 6
closes Nov 5
VURLIPAV · Cl. 5 · published Oct 6
closes Nov 5
CILBIQTY · Cl. 5 · published Oct 20
closes Nov 19
NOVARTIS RLT NOW · Cl. 42, 44 · published Oct 20
closes Nov 19

Anyone who believes they would be harmed by registration can oppose during this window.

Recently registeredlast 12 months
RHAPSIDO · Cl. 5 · Reg. 8,487,710
Oct 6, 2026
ZENLUMIQA · Cl. 5 · Reg. 8,465,897
Sep 29, 2026
STARTED WITH A GENE · Cl. 35 · Reg. 8,451,254
Sep 22, 2026
STARTED WITH A GENE · Cl. 35 · Reg. 8,424,429
Sep 1, 2026
BEXJUXI · Cl. 5 · Reg. 8,407,942
Aug 25, 2026
QXISTYM · Cl. 5 · Reg. 8,407,951
Aug 25, 2026
XIVVOET · Cl. 5 · Reg. 8,407,952
Aug 25, 2026
CLEARSEE · Cl. 5, 10 · Reg. 8,350,288
Jul 21, 2026

Registration starts the maintenance clock: a Section 8 declaration is due between years 5 and 6.

Maintenance windows aheadnext 12 months · from registration dates
MSGO · Reg. 6,039,451 · registered Apr 2020
Section 8 declaration (years 5–6) · in grace period until Oct 28, 2026
Apr 28, 2025 → Apr 28, 2026
KINVITAR · Reg. 6,061,245 · registered May 2020
Section 8 declaration (years 5–6) · in grace period until Nov 26, 2026
May 26, 2025 → May 26, 2026
VYNCEDE · Reg. 6,082,595 · registered Jun 2020
Section 8 declaration (years 5–6) · in grace period until Dec 23, 2026
Jun 23, 2025 → Jun 23, 2026
VLODIC · Reg. 6,082,600 · registered Jun 2020
Section 8 declaration (years 5–6) · in grace period until Dec 23, 2026
Jun 23, 2025 → Jun 23, 2026
ETTALAS · Reg. 6,082,601 · registered Jun 2020
Section 8 declaration (years 5–6) · in grace period until Dec 23, 2026
Jun 23, 2025 → Jun 23, 2026
CASTEXCIM · Reg. 6,087,977 · registered Jun 2020
Section 8 declaration (years 5–6) · in grace period until Dec 30, 2026
Jun 30, 2025 → Jun 30, 2026
VELCEMLI · Reg. 6,087,978 · registered Jun 2020
Section 8 declaration (years 5–6) · in grace period until Dec 30, 2026
Jun 30, 2025 → Jun 30, 2026
ONSCEMBL · Reg. 6,087,979 · registered Jun 2020
Section 8 declaration (years 5–6) · in grace period until Dec 30, 2026
Jun 30, 2025 → Jun 30, 2026

A filing missed by the due date enters a six-month grace period, then the registration cancels.

Names on the registerwhat this page merges, and what it leaves out
Novartis AG · 953 live marks
included
NOVARTIS CORPORATION · 11 live marks
included
Novartis Pharma AG · 51 live marks · may be a related company
separate page

Spellings are merged when they differ only in punctuation or legal suffix. Anything else stays separate rather than guessed.

Common questions

About Novartis AG trademarks.

How many trademarks does Novartis AG have?

964 live US trademarks as of October 23, 2026: 854 registered and 110 pending applications. 38 were filed in 2026 so far.

What does Novartis AG sell, according to its trademarks?

Mostly pharmaceuticals (Class 5, 800 live marks). Also medical & beauty services (Class 44) and medical devices (Class 10).

Who owns the METHERGINE trademark?

METHERGINE is owned by Novartis AG. It was registered on April 6, 1943 (Reg. No. 0400893) and is live. The same owner holds 963 other live US marks.

When did Novartis AG first file a trademark?

Its oldest live US filing dates from 1942: METHERGINE, filed November 18, 1942.

Know the morning after Novartis AG files.

Watch this company in Thorgate and get an alert for every new application, registration, publication and lapse, with the opposition deadline already worked out. Or monitor your own marks for conflicts with theirs.

Data: USPTO trademark bulk files, processed nightly by Thorgate. Last rebuilt October 23, 2026. Counts cover the US federal register only, not state or foreign marks. Owner names are shown as recorded by the USPTO. This page reports public-record facts and dates and is not legal advice. For the official record of any mark, follow its serial number to USPTO TSDR.